… ) derived scaffold, with an angiogenic growth factor immobilized … porous
polycaprolactone/hydroxyapatite (PCL/HA) scaffold is … factor (VEGF) by coprecipitation with …

… polycaprolactone (PCL) scaffolds by the delivery of endothelial progenitor cells (EPCs).
To establish a pro-angiogenic … employed EPCs seeded in PCL scaffold with surface-immobilized …

… polycaprolactone-collagen fibrous scaffold is reported to promote early osteogenesis and
angiogenesis. Simvastatin as a pro-angiogenic … pro-angiogenic drug promotes angiogenesis. …

… Using these scaffolds as engraftment platforms, we assess their potential to augment the
proangiogenic effects of iPSC-ECs following implantation in vivo. Through gene expression …

… regenerative capacity including migratory and proangiogenic potential, which are required
for effective vascular repair in vivo. Thus, PLA and PCL-based scaffolds combined with hUC-…

… factors. Although various strategies have been devised to deliver pro-angiogenic growth factors,
… [4], the problem of inadequate blood vessels within scaffolds remains at large. Even with …

… factor mediated mechanisms. Here, we report the fabrication of electrospun polycaprolactone
scaffolds … by the expression of key proangiogenic factors, fibroblast growth factor (FGF) and …

… scaffold platform, consisting of polycaprolactone (PCL) nanofibers and vascular endothelial
growth factor (… The results showed that this kind of scaffold can direct the differentiation of …

… between ECs and osteoblast cells occurs via diffusible factors as well as direct cell–cell …
the soluble factor examined in this study since it is a powerful pro-angiogenic factor with well …

… , resorbable PCL scaffold would provide a novel superior composite scaffold that facilitates
… a pro-angiogenic fibrin-based biomaterial component (fibrin/alginate) as part of the scaffold …